Cero Therapeutics Holdings Inc (CERO)

Dec 26, 2024

Top 5 Biotech Stocks That Captured Retail Investor Interest The Most In 2024 - Asianet Newsable

Dec 26, 2024

Dec 18, 2024

Why Corvus Pharmaceuticals Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket - Benzinga

Dec 18, 2024

Dec 14, 2024

Cero Therapeutics holdings sees $400,456 in stock sales by YK Bioventures - Investing.com Australia

Dec 14, 2024

Dec 10, 2024

Cero Therapeutics sees $383,369 in stock sales by YK Bioventures - Investing.com

Dec 10, 2024

Dec 07, 2024

CERo Therapeutics appoints Chris Ehrlich CEO - MSN

Dec 07, 2024

Dec 06, 2024

CERo Therapeutics Holdings, Inc. Appoints Chris Ehrlich CEO - Marketscreener.com

Dec 06, 2024

Dec 06, 2024

CERo Therapeutics, Inc. Appoints Chris Ehrlich CEO - GlobeNewswire

Dec 06, 2024

Dec 06, 2024

CERo Therapeutics Names Chris Ehrlich Permanent CEO, Advances Novel Cancer Treatment Pipeline - StockTitan

Dec 06, 2024

Nov 21, 2024

Cero therapeutics investor Sloan Stuart sells $55,538 in stock By Investing.com - Investing.com India

Nov 21, 2024

Nov 20, 2024

U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.70% - MSN

Nov 20, 2024

Nov 20, 2024

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.69% - MSN

Nov 20, 2024

Nov 20, 2024

United States shares lower at close of trade; Dow Jones Industrial Average down 0.70% - MSN

Nov 20, 2024

Nov 20, 2024

CERo Therapeutics Holdings Inc. (CERO) reports earnings - Quartzy

Nov 20, 2024

Nov 16, 2024

Selling Your CERo Therapeutics Holdings Inc (CERO) Stock? Here’s What You Need To Know - Stocks Register

Nov 16, 2024

Nov 15, 2024

Cero Therapeutics holdings sees $325,000 stock sale by YK Bioventures - Investing.com India

Nov 15, 2024

Nov 15, 2024

FDA clears CERo's new AML drug for phase 1 trials - Investing.com

Nov 15, 2024

Nov 15, 2024

FDA clears CERo's new AML drug for phase 1 trials By Investing.com - Investing.com UK

Nov 15, 2024

Nov 15, 2024

CERo Therapeutics, Inc. Receives FDA Clearance of - GlobeNewswire

Nov 15, 2024

Nov 15, 2024

CERo Therapeutics Secures FDA Clearance for Novel AML Treatment Clinical Trial | CERO Stock News - StockTitan

Nov 15, 2024

Nov 14, 2024

Pre-market Movers: ELAB, PHGE, CLDI, BJDX... - RTTNews

Nov 14, 2024

Nov 13, 2024

Nuclear stock Oklo jumps on data center partnership - Investing.com

Nov 13, 2024

Nov 12, 2024

U.S. Stock market most volatile stocks: Neuronetics(-47.27%), Heron Therapeutics(-20.15%) and LogicMark(+94.36%) in early trading - Business Upturn

Nov 12, 2024

Nov 12, 2024

CERo Therapeutics’ (CERO) Stock Sees Significant Climb After Revealing Ovarian Cancer Data - TipRanks

Nov 12, 2024

Nov 11, 2024

United Therapeutics (UTHR) Stock Dips Amid Broader Biotech Indus - GuruFocus.com

Nov 11, 2024

Nov 11, 2024

CERo Therapeutics Holdings, Inc. (CERO): 173% Stock Surge Driven by Promising Preclinical Data for Lead Compound CER-1236 - BP Journal

Nov 11, 2024

Nov 11, 2024

Crude Oil Down 3%; Aramark Posts Upbeat Earnings - Benzinga

Nov 11, 2024

Nov 11, 2024

Nasdaq Moves Lower; Canaan Shares Surge - Benzinga

Nov 11, 2024

Nov 11, 2024

U.S. Stock market: Binah Capital Group(+105.01%) and CERo Therapeutics(+152.00%) see strong gains, RAPT Therapeutics(−44.12%) declines during mid day trading - Business Upturn

Nov 11, 2024

Nov 11, 2024

U.S. Stock market: RAPT Therapeutics drops 41% while CERo Therapeutics surges 136% in early trading - Business Upturn

Nov 11, 2024

Nov 11, 2024

Dow Jumps Over 400 Points; Monday.com Shares Fall After Q3 Results - Benzinga

Nov 11, 2024

Nov 11, 2024

CERo Therapeutics, Inc. Presents Preclinical Data - GlobeNewswire

Nov 11, 2024

Nov 11, 2024

CERo's Cancer Drug Shows Breakthrough: Kills Ovarian Cancer Without Toxicity in Key Study | CERO Stock News - StockTitan

Nov 11, 2024

Nov 05, 2024

Decisive Dividend Corp (DE-X) QuotePress Release - The Globe and Mail

Nov 05, 2024

Nov 01, 2024

Cero Therapeutics faces NASDAQ delisting - Investing.com India

Nov 01, 2024

Nov 01, 2024

Cero Therapeutics faces NASDAQ delisting By Investing.com - Investing.com UK

Nov 01, 2024

Oct 26, 2024

Cero Therapeutics Faces NASDAQ Delisting Over Low Stock Price - Investing.com India

Oct 26, 2024

Oct 21, 2024

CERo Therapeutics updates on clinical hold and management changes - Investing.com India

Oct 21, 2024

Oct 21, 2024

CERo Therapeutics updates on clinical hold and management changes By Investing.com - Investing.com South Africa

Oct 21, 2024

Oct 21, 2024

CERo Therapeutics Holdings, Inc. Announces Submission of IND Clinical Hold Complete Response Letter - Marketscreener.com

Oct 21, 2024

Oct 21, 2024

CERo Therapeutics, Inc. Provides Corporate Update - The Bakersfield Californian

Oct 21, 2024

Oct 15, 2024

CERO’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle

Oct 15, 2024

Oct 15, 2024

Are Investors Inclined To Sell Their CERo Therapeutics Holdings Inc. (NASDAQ: CERO) Holdings? - Stocks Register

Oct 15, 2024

Oct 14, 2024

A closer look at CERO’s price-to-free cash flow ratio - US Post News

Oct 14, 2024

Oct 14, 2024

CERo Therapeutics Holdings Inc.’s Market Journey: Closing Strong at 0.10, Up 0.63 - The Dwinnex

Oct 14, 2024

Oct 14, 2024

Take off with CERo Therapeutics Holdings Inc. (CERO): Get ready for trading - SETE News

Oct 14, 2024

Oct 14, 2024

Cero Therapeutics announces financial update and board changes - Investing.com India

Oct 14, 2024